Table_5_Acupuncture for premature ventricular complexes without ischemic or structural heart diseases: A systematic review and meta-analysis of clinical and pre-clinical evidence.D... by Yiyi Cai (6638486)

“…</p>Results<p>A total of 479 records were identified with nine trials involving 847 participants included in this review. …”

Functional and structural polarization of human breast epithelial cell organoids grown at 21% and 1% oxygen illustrated by the marker of breast epithelial differentiation and polar... by Marica Vaapil (132671)

“…HMFG/MUC1 displayed a decrease in polarized localization in both primary breast epithelial and MCF-10A cells at hypoxia (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0046543#pone-0046543-g005" target="_blank">Fig. 5</a>A, B). …”

In combination with our previous report [<b>5</b>], we have created an overview of the early molecular response comparing woven to lamellar bone formation. by Jennifer A. McKenzie (190618)

Data_Sheet_2_A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing.PDF by Maria T. Arévalo (6640280)

“…<p>A new human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; including fever, shortness of breath, and coughing. …”

Data_Sheet_1_A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing.FASTA by Maria T. Arévalo (6640280)

“…<p>A new human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; including fever, shortness of breath, and coughing. …”

TOP2α/170 mRNA and protein levels in K562, drug resistant K/VP.5, and K562/SSedit-2 cells. by Victor A. Hernandez (12647320)

“…Subsequent reduced coverage for E20 in K/VP.5 cells (underlined in black/denoted with a red arrow) is consistent with decreased TOP2α/170 protein expression levels (see Fig 5E). …”

Image_5_ARID5B regulates fatty acid metabolism and proliferation at the Pre-B cell stage during B cell development.tif by Jaya Prakash Chalise (16506906)

“…Dysregulation of this process may result in the failure to produce functional B cells and pose a risk of leukemic transformation. Here, we report that AT rich interacting domain 5B (ARID5B), a B cell acute lymphoblastic leukemia (B-ALL) risk gene, regulates B cell development at the Pre-B stage. …”

Table_2_KANK2 Links αVβ5 Focal Adhesions to Microtubules and Regulates Sensitivity to Microtubule Poisons and Cell Migration.xlsx by Mladen Paradžik (8522163)

“…MS analysis showed that cells preferentially use integrin αVβ5 for the formation of IACs. The differential analysis between MDA-MB-435S cells and clones with decreased expression of integrin αV identified key components of integrin αVβ5 adhesion complexes as talins 1 and 2, α-actinins 1 and 4, filamins A and B, plectin and vinculin. …”

Table1_TFP5-Mediated CDK5 Activity Inhibition Improves Diabetic Nephropathy via NGF/Sirt1 Regulating Axis.DOCX by Shi-Lu Cao (13010034)

“…TFP5, a 25-amino acid peptide inhibiting CDK5 activity, decreased the secretion of inflammation cytokines in serum and kidney, and effectively protected the kidney function in db/db mouse from hyperglycemia-induced kidney injuries. …”

Table3_TFP5-Mediated CDK5 Activity Inhibition Improves Diabetic Nephropathy via NGF/Sirt1 Regulating Axis.XLS by Shi-Lu Cao (13010034)

“…TFP5, a 25-amino acid peptide inhibiting CDK5 activity, decreased the secretion of inflammation cytokines in serum and kidney, and effectively protected the kidney function in db/db mouse from hyperglycemia-induced kidney injuries. …”

RNAi-based screen for genes that modify aSyn oligomerization in living cells. by Susana A. Gonçalves (199613)

“…</b> Representative live cell imaging pictures of aSyn-BiFC stable H4 cells silenced for hits that increase (<i>RAB8B</i>, <i>RAB11A</i>, <i>RAB13</i>, <i>RAB39B</i>, <i>CAMK1</i>, <i>DYRK2</i>) or decrease (<i>CC2D1A</i>, <i>CLK4</i>, <i>SYTL5)</i> aSyn oligomerization (green). …”

Absence of LAMP5 disrupts olfaction and leads to anxiety-like behavior. by Marie-Catherine Tiveron (272288)

The overall negative effects played by IFITM3 during viral spread are the result of two concomitant antiviral mechanisms, acting in the protection of target cells as well as in the... by Kevin Tartour (514249)

Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

“…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­(NHC)­(OC­(CF₃)₃)⁺ B­(Ar^F)₄^– (NHC = IMes (<b>1</b>), IMesCl₂ (<b>2</b>), IMesMe₂ (<b>3</b>), and IMesH₂ (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­((OC­(CF₃)₃))₂ (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”

Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

“…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­(NHC)­(OC­(CF₃)₃)⁺ B­(Ar^F)₄^– (NHC = IMes (<b>1</b>), IMesCl₂ (<b>2</b>), IMesMe₂ (<b>3</b>), and IMesH₂ (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­((OC­(CF₃)₃))₂ (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”

Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

“…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­(NHC)­(OC­(CF₃)₃)⁺ B­(Ar^F)₄^– (NHC = IMes (<b>1</b>), IMesCl₂ (<b>2</b>), IMesMe₂ (<b>3</b>), and IMesH₂ (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­((OC­(CF₃)₃))₂ (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”

Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

“…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­(NHC)­(OC­(CF₃)₃)⁺ B­(Ar^F)₄^– (NHC = IMes (<b>1</b>), IMesCl₂ (<b>2</b>), IMesMe₂ (<b>3</b>), and IMesH₂ (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­((OC­(CF₃)₃))₂ (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”

Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

“…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­(NHC)­(OC­(CF₃)₃)⁺ B­(Ar^F)₄^– (NHC = IMes (<b>1</b>), IMesCl₂ (<b>2</b>), IMesMe₂ (<b>3</b>), and IMesH₂ (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­((OC­(CF₃)₃))₂ (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”

Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

“…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­(NHC)­(OC­(CF₃)₃)⁺ B­(Ar^F)₄^– (NHC = IMes (<b>1</b>), IMesCl₂ (<b>2</b>), IMesMe₂ (<b>3</b>), and IMesH₂ (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me₂C₆H₃)­(CHCMe₂Ph)­((OC­(CF₃)₃))₂ (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”

Image_5_COVID-19 patients display changes in lymphocyte subsets with a higher frequency of dysfunctional CD8lo T cells associated with disease severity.tif by Luisina Ines Onofrio (17018217)

“…In addition, these patients showed a decreased frequency in IL-2-producing T conv cells. …”